Challenges in severe asthma: Do we need new drugs or new biomarkers?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.921967
Abstract: Severe asthma is a complex, heterogenous airway condition. There have been significant advances in severe asthma management in the past decade using monoclonal antibody therapies that target the inflammatory component of the disease. Patient selection… read more here.
Keywords: new drugs; drugs new; asthma need; need new ... See more keywords